OpenVSafe by OpenVAERS
Search V-safe

DT9-13668-34429

2 vaccinations 11 coded responses 22 check-ins 11 free-text entries 4 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
450 / OH
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-25
    Health check-in — day 7, dose 1
    Feeling: Fair · Fever · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-04-01
    Survey response — day 14, dose 1
    MedDRA: Heart rate increased, Pre-existing disease — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Asthma; increased heart rate.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-01
    Report sent to call center — day 14, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-04-10
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-10
    Health check-in — day 0, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-04-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-04-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Asthma, Dyspnoea, Pre-existing disease — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Shortness of Breath/Pre-existing asthma
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-04-17
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-24
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Night sweats — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: I am having night sweats. They started when I received my second vaccination. And the exhaustion has never went away since my first vaccunation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-01
    Survey response — day 21, dose 2
    MedDRA: Abdominal pain, Dyspnoea, Hyperhidrosis, Night sweats — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Shortness of breath; increased night sweats. Presence with day sweats not doing phydical activity. Abfominal pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-08
    Survey response — day 28, dose 2
    MedDRA: Dyspnoea, Fatigue, Injection site pain, Night sweats — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Still shortness of breath, exhaustion, and night sweats (no fevet). Still have sharp pains ar injection site that come and go.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-17
    Survey response — day 35, dose 2
    MedDRA: Dyspnoea, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Shortness of breath and exhaustion symptoms still present.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-24
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-06-09
  25. 2021-07-10
    Survey response — 3 months, dose 2
    MedDRA: Hernia, Hernia repair — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Hospitalization
    Free text: Out of the blue I developed an emergency hernia that needed repaired.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-07-10
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  27. 2021-07-20
  28. 2021-10-10
    Survey response — 6 months, dose 2
    MedDRA: Type 2 diabetes mellitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Type 2 Diabetes
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-10
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2021-10-12
  31. 2022-04-10
    Survey response — 12 months, dose 2
    MedDRA: Type 2 diabetes mellitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Type 2 Diabetes
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-04-10
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  33. 2022-04-13

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech
22021-04-10Pfizer-BioNTech

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 6 — day 14, dose 1

2021-04-01

Symptoms: Asthma; increased heart rate.

Release 7 — days 1–6 daily, dose 2

2021-04-11

Systemic reaction (other): Dizziness

2021-04-12

Systemic reaction (other): Dizziness

2021-04-14

Systemic reaction (other): Shortness of Breath/Pre-existing asthma

Release 7 — day 14, dose 2

2021-04-24

Symptoms: I am having night sweats. They started when I received my second vaccination. And the exhaustion has never went away since my first vaccunation.

Release 8 — day 21, dose 2

2021-05-01

Symptoms: Shortness of breath; increased night sweats. Presence with day sweats not doing phydical activity. Abfominal pain.

Release 8 — day 28, dose 2

2021-05-08

Symptoms: Still shortness of breath, exhaustion, and night sweats (no fevet). Still have sharp pains ar injection site that come and go.

Release 8 — day 35, dose 2

2021-05-17

Symptoms: Shortness of breath and exhaustion symptoms still present.

Release 9 — 3 months, dose 2

2021-07-10

Symptoms: Out of the blue I developed an emergency hernia that needed repaired.

Release 10 — 6 months, dose 2

2021-10-10

Symptoms: Type 2 Diabetes

Release 11 — 12 months, dose 2

2022-04-10

Symptoms: Type 2 Diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDHernia ✓ ✓ ✓
SDHernia repair ✓ ✓ ✓
SDHyperhidrosis ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDNight sweats ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDType 2 diabetes mellitus · · ✓
SROAsthma ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release